• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quotient appoints Christopher Lindop chief financial officer

Quotient appoints Christopher Lindop chief financial officer

February 13, 2017
CenterWatch Staff

Quotient, a commercial-stage diagnostics company, has announced the appointment of Christopher Lindop as chief financial officer. Lindop will commence his new role on February 15, 2017. 

Lindop joins Quotient with more than a decade of financial leadership experience within high-growth diagnostic and blood management companies. Most recently, Lindop served as chief financial officer and executive vice president of Business Development at Haemonetics Corporation (HAE), a publicly traded hematology management company, where he oversaw financial organization, strategic planning, business development and investor relations during a period of rapid growth. Prior to joining Haemonetics in January 2007, Lindop served as chief financial officer at Inverness Medical Innovations, now Alere, a publicly traded diagnostics company, where he developed a financial infrastructure to support rapid expansion and led multiple financings. Prior to joining Inverness, Lindop was a partner at both Arthur Andersen and Ernst & Young. Lindop currently serves on the board of directors at Parexel International (PRXL), a publicly traded biopharmaceutical consulting company.

“We are excited to have Chris join us during such a pivotal period as we work towards the commercial launch of MosaiQ,” said Paul Cowan, Quotient’s chairman and chief executive officer. “His vast experience in helping to lead diagnostic and blood management companies through periods of high growth will be invaluable.” 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing